Cargando…
Predictors of Morphine Efficacy for Dyspnea in Inpatients with Chronic Obstructive Pulmonary Disease: A Secondary Analysis of JORTC-PAL 07
Objective: This study aimed to explore the predictors of morphine efficacy in the alleviation of dyspnea in COPD. Background: Dyspnea is prevalent in patients with chronic obstructive pulmonary disease (COPD) and often persists despite conventional treatment. Methods: A secondary analysis of a multi...
Autores principales: | Matsuda, Yoshinobu, Morita, Tatsuya, Matsumoto, Hirotaka, Hosoi, Keita, Kusama, Kayo, Kohashi, Yasuo, Morishita, Hiroshi, Kaku, Sawako, Ariyoshi, Keisukie, Oyamada, Shunsuke, Inoue, Yoshikazu, Iwase, Satoru, Yamaguchi, Takuhiro, Nishikawa, Mitsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241369/ https://www.ncbi.nlm.nih.gov/pubmed/34223498 http://dx.doi.org/10.1089/pmr.2020.0078 |
Ejemplares similares
-
Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)
por: Matsuda, Yoshinobu, et al.
Publicado: (2021) -
Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09)
por: Iwase, Satoru, et al.
Publicado: (2015) -
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol
por: Matsuoka, Hiromichi, et al.
Publicado: (2022) -
The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02)
por: Nishiyama, Nanako, et al.
Publicado: (2020) -
Efficacy of oral administration of cystine and theanine in colorectal cancer patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03)
por: Hamaguchi, Reo, et al.
Publicado: (2019)